Back to search

Mature But Not Immature Fas Ligand (CD95L)-Transduced Human Monocyte-Derived Dendritic Cells Are Protected from Fas-Mediated Apoptosis and Can Be Used as Killer APC

Data up to Jan 2025

Published2003
Citations36
References56

Total Citations Per Year

Abstract

References (56)

Dendritic cells and the control of immunity

1998 • 14,345 citations

The Dendritic Cell System and its Role in Immunogenicity

1991 • 4,733 citations

Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family

1993 • 2,546 citations

Mouse and human dendritic cell subtypes

2002 • 2,311 citations

Antigen Presentation and T Cell Stimulation by Dendritic Cells

2002 • 1,860 citations

CD95's deadly mission in the immune system

2000 • 1,714 citations

Induction of Interleukin 10–Producing, Nonproliferating Cd4+ T Cells with Regulatory Properties by Repetitive Stimulation with Allogeneic Immature Human Dendritic Cells

2000 • 1,577 citations

Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?

2002 • 1,343 citations

Induction of tolerance by IL-10-treated dendritic cells.

1997 • 1,263 citations

Pro‐inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum‐free conditions

1997 • 1,179 citations

Conversion of Membrane-bound Fas(CD95) Ligand to Its Soluble Form Is Associated with Downregulation of Its Proapoptotic Activity and Loss of Liver Toxicity

1998 • 789 citations

Downregulation of Fas ligand by shedding

1998 • 681 citations

The JAM test A simple assay for DNA fragmentation and cell death

1991 • 632 citations

Membrane Fas Ligand Kills Human Peripheral Blood T Lymphocytes, and Soluble Fas Ligand Blocks the Killing

1997 • 503 citations

Methods for construction of adenovirus vectors

1995 • 483 citations

Immune escape of tumors: apoptosis resistance and tumor counterattack

2002 • 453 citations

Flt3 ligand induces tumor regression and antitumor immune responses in vivo

1997 • 315 citations

Dendritic Cells Genetically Engineered to Express Fas Ligand Induce Donor-Specific Hyporesponsiveness and Prolong Allograft Survival

2000 • 237 citations

Opposing Effects of Transmembrane and Soluble FAS Ligand Expression on Inflammation and Tumor Cell Survival

2000 • 236 citations

FAS Engagement Induces the Maturation of Dendritic Cells (Dcs), the Release of Interleukin (Il)-1β, and the Production of Interferon γ in the Absence of IL-12 during Dc–T Cell Cognate Interaction

2000 • 230 citations

Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells

1999 • 226 citations

Viral vectors for dendritic cell-based immunotherapy

2001 • 180 citations

Soluble Fas Ligand Is Chemotactic for Human Neutrophilic Polymorphonuclear Leukocytes

1999 • 175 citations

Induction of antigen-specific immunosuppression by CD95L cDNA-transfected 'killer' dendritic cells

1999 • 159 citations

Chemotactic activity of soluble Fas ligand against phagocytes.

1998 • 159 citations

Comparative analysis of integrin expression on monocyte‐derived macrophages and monocyte‐derived dendritic cells

2000 • 133 citations

Innate Direct Anticancer Effector Function of Human Immature Dendritic Cells. II. Role of TNF, Lymphotoxin-α1β2, Fas Ligand, and TNF-Related Apoptosis-Inducing Ligand

2002 • 131 citations

Induction of Specific T Cell Tolerance by Fas Ligand- Expressing Antigen-Presenting Cells

1999 • 131 citations

Dendritic Cells Are Resistant to Apoptosis Through the Fas (CD95/APO-1) Pathway

1999 • 124 citations

Cutting Edge: Chemotactic Activity of Soluble Fas Ligand Against Phagocytes

1998 • 123 citations

Apoptosis of mouse naive T cells induced by recombinant soluble Fas ligand and activation-induced resistance to Fas ligand.

1996 • 116 citations

Expression of c-FLIPL and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: inhibition by bisindolylmaleimide

2000 • 112 citations

Expression of c-FLIPL and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: inhibition by bisindolylmaleimide

2000 • 95 citations

Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: A potential treatment strategy for Epstein-Barr virus-positive Hodgkin's lymphoma

2001 • 86 citations

Induction of specific T-cell tolerance by adenovirus-transfected, Fas ligand-producing antigen-presenting cells

1998 • 86 citations

CD40 ligand inhibits Fas/CD95‐mediated apoptosis of human blood‐derived dendritic cells

1997 • 81 citations

Membrane Fas Ligand Activates Innate Immunity and Terminates Ocular Immune Privilege

2002 • 81 citations

Ultraviolet Light-Induced Immune Tolerance Is Mediated via the Fas/Fas-Ligand System

1998 • 74 citations

Mature dendritic cells are protected from Fas/CD95-mediated apoptosis by upregulation of Bcl-X L

2002 • 59 citations

Antigen presenting cells expressing Fas ligand down-modulate chronic inflammatory disease in Fas ligand–deficient mice

2000 • 57 citations

Increased Survival in Sepsis by In Vivo Adenovirus-Induced Expression of IL-10 in Dendritic Cells

2002 • 56 citations

Feasibility of CTLA4Ig gene delivery and expression in vivo using retrovirally transduced myeloid dendritic cells that induce alloantigen-specific T cell anergy in vitro

2000 • 51 citations

Treatment of chronic sialadenitis in a murine model of Sj�gren's syndrome by localfasL gene transfer

2001 • 50 citations

Retroviral delivery of transforming growth factor-??1 to myeloid dendritic cells: inhibition of T-cell priming ability and influence on allograft survival12

2002 • 46 citations

Immunosuppressive properties of CD95L-transduced “killer” hybrids created by fusing donor- and recipient-derived dendritic cells

2001 • 45 citations

Transduction of donor hematopoietic stem-progenitor cells with Fas ligand enhanced short-term engraftment in a murine model of allogeneic bone marrow transplantation

2002 • 38 citations

Application of a Fas Ligand Encoding a Recombinant Adenovirus Vector for Prolongation of Transgene Expression

1998 • 33 citations

Dendritic Cells for Specific Cancer Immunotherapy

2001 • 29 citations

Killing of naive T cells by CD95L-transfected dendritic cells (DC):in vivo study using killer DC-DC hybrids and CD4+ T cells from DO11.10 mice

2002 • 26 citations

Down-regulation of human alloimmune responses by genetically engineered expression of CD95 ligand on stimulatory and target cells

2001 • 26 citations

Reduction of Antiviral CD8 Lymphocytes In Vivo with Dendritic Cells Expressing Fas Ligand—Increased Survival of Viral (Lymphocytic Choriomeningitis Virus) Central Nervous System Infection

2002 • 25 citations

Antigen-Specific Induction of Peripheral T Cell Tolerancein Vivoby Codelivery of DNA Vectors Encoding Antigen and Fas Ligand

2000 • 24 citations

Specific Immunotherapy by Genetically Engineered APCs: The “Guided Missile” Strategy

2001 • 23 citations

Construction, Propagation, and Titer Estimation of Recombinant Adenoviruses Carrying Proapoptotic Genes

1998 • 18 citations

Construction of a recombinant adenovirus vector encoding fas ligand with a CRE/Loxp inducible system

1999 • 13 citations

B cells engineered to express Fas ligand suppress pre-sensitized antigen-specific T cell responses in vivo

2002 • 11 citations

Cited By (0)

Loading...
Mature But Not Immature Fas Ligand (CD95L)-Transduced Human Monocyte-Derived Dendritic… (2003) – The Journal of Immunology | Metascience Observatory Explorer